Washington, Mar. 22 (beraking latest news Health) – The anti-Covid vaccine developed by AstraZeneca and the University of Oxford is safe and effective. This is confirmed by a phase 3 study that involved more than 32 thousand volunteers, most of them in the United States, but also in Chile and Peru. From the data analyzed, it appears that the vaccine is 79% effective in preventing symptomatic Sars-CoV-2 infection and 100% in avoiding severe disease. Regarding thromboembolic risks, no safety issues have been reported.
“These results are great news – Andrew Pollard, the head of the vaccine trial at Oxford University, told the BBC – as they show the remarkable effectiveness of the vaccine in a new population and are consistent with the results of the studies conducted. from Oxford “.
COPYRIGHT today © breaking latest news